Overexpressing SIRT3 partially restores the inhibition of cell proliferation and migration in fraxinellone-treated GBM cells, indicating a protective role against fraxinellone’s effects and highlighting its importance in GBM progression signaling pathways [91]. The gene discussed is SIRT3; the disease is glioblastoma.